AI

#AI #Drug development #Sofinnova Partners

Ingenix raises €13m to scale AI drug development model 

AI company Ingenix has announced it has raised €13 million to scale its drug development model.  Ingenix says its Biological Reasoning Engine overcomes structural problems in AI drug development, integrating best-in-class models across modalities and biological scales.  The model was applied to a dual-payload ADC prioritisation… Read More

#News

#AI #Clinical trial #MHRA

First AI drug enters clinical development 

The first oral drug formulated by AI has been advanced into clinical development.  CRDMO Quotient Sciences has announced a Phase I study of the drug was initiated at the company’s UK facility following approval from the Medicines and Healthcare products Regulatory Agency (MHRA).   The study will… Read More

#News

#AI #Assays #Drug discovery #Lab automation #STEM

How to improve lab education

Dr Tim Meyer, Research Group Leader Pharmaceutical Biotechnology at University Medical Center Göttingen, explains why the next generation of scientists must be trained differently for the lab.   Academic life science research has traditionally been optimised for novelty. Students and early-career researchers are trained to design elegant proof-of-concept experiments, execute them manually,… Read More

#Exclusive Content #Opinion

AI clinical trials concept
#AI #Clinical trial #Pistoia Alliance

Trust and regulation holding back AI in clinical trials 

The use of AI in clinical trials is being held back by a lack of trust and regulatory uncertainty, professionals say.  A poll from The Pistoia Alliance found that half of respondents agreed trust and regulatory uncertainty were barriers to AI adoption in clinical trials. … Read More

#News

#AI #Collaborative Drug Discovery (CDD) #Eli Lilly

CDD to make Eli Lilly models available in CDD Vault 

Collaborative Drug Discovery (CDD) has announced an agreement with Eli Lilly to make Lilly’s AI/ML models available in CDD Vault.  The models will come from Lilly TuneLab, the platform created by Lilly to accelerate biotech innovation by enabling participating companies to access models trained on decades of Lilly’s… Read More

#News

#AI #Autoimmune disease #Breast cancer #Clinical trial #Cystic fibrosis #Diabetes #FDA #Fractyl Health #Gene therapy #GLP-1 #Institute of Cancer Research #Oncology #Phesi

This week in Drug Discovery (18 – 22 May)

News round-up for 18 – 22 May by Bruno Quinney, Content Team at DDW.    This week, a report showed patients in Europe face barriers to patient access. Elsewhere, Wellcome prizes are facilitating research in both tropical disease and mental health.    The… Read More

#News

#AI #Antimicrobial resistance (AMR) #Drug discovery #Genomics #India #Oncology

India: Who should we be watching in the drug discovery space?

Diana Turner takes a look at drug discovery in India, a country making the shift from scale to innovation.  While the Indian pharmaceuticals sector has long held a key global position as a centre for generics development and manufacturing, the country is beginning to make a significant name for itself as a… Read More

#Exclusive Content

Scientist in laboratory
#AI #Clinical trial #iOnctura #Poolbeg Pharma #Regulatory #Synklino #Weatherden

Expert opinion: Navigating the challenges in the clinical trials sector

On International Clinical Trials Day, industry experts speak to DDW about the current state of play within global clinical trials. DDW: How encouraged are you by regulatory reforms – whether it’s a focus on the use of NAMs, or faster regulatory review processes – to help companies conduct more efficient and effective trials? Liam Tremble: A lot… Read More

#Exclusive Content #Regulatory

#AI #Drug discovery #Genomics #Multiomics #Transcriptomics

Advances in genomics for drug discovery 

DDW Editor Reece Armstrong speaks to Michelle Carlson about overall advances in genomics and the integration of emerging technologies to create more drug discovery and development opportunities.  RA: How is long-read sequencing enabling greater clinical research in genomics? MC: Short-read sequencing is effective for identifying single-nucleotide mutations and other small variants that can cause genetic disease. Read More

#Exclusive Content

#AI #Autoimmune disease #Breast cancer #Clinical trial #Cystic fibrosis #Diabetes #FDA #Fractyl Health #Gene therapy #GLP-1 #Institute of Cancer Research #Oncology #Phesi

DDW Highlights: 19 May 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, research uncovered new treatment pathways for hard to treat breast cancers. Elsewhere,… Read More

#Podcasts

#AI #Autoimmune disease #Breast cancer #Clinical trial #Cystic fibrosis #Diabetes #FDA #Fractyl Health #Gene therapy #GLP-1 #Institute of Cancer Research #Oncology #Phesi

This week in Drug Discovery (11 – 15 May) 

News round-up for 11 – 15 May by Bruno Quinney, Content Team at DDW.  This week, research has uncovered new treatment pathways for hard to treat breast cancers. Elsewhere, therapies given the green light could combat type 2 diabetes and generalised myasthenia gravis.  The top stories:   … Read More

#News

Scientist in laboratory
#AI #Clinical trial #Phesi

AI not solving clinical trial flaws, report says 

AI tools are scaling flaws in clinical trials instead of solving them, analysis shows.  Analytics and data company Phesi revealed the findings from a global analysis of more than 600,000 clinical trial protocols.   Results show fewer than one in three (29.3%) protocols are linked to publicly documented patient… Read More

#News

#AI #ALS #Cancer Research Horizons #Cancer Research UK #FDA #Malaria #Mergers and acquisitions #Oncology #Real-time clinical trials #Regulatory #Spinogenix #University of Bath #University of Leeds

DDW Highlights: 12 May 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, the FDA advanced an initiative to implement real-time clinical trials. Elsewhere, UCB made… Read More

#Podcasts

#AI #ALS #Cancer Research Horizons #Cancer Research UK #FDA #Malaria #Mergers and acquisitions #Oncology #Real-time clinical trials #Regulatory #Spinogenix #University of Bath #University of Leeds

This week in Drug Discovery (4 – 8 May) 

News round-up for 4 – 8 May by Bruno Quinney, Content Team at DDW.  This week, the FDA has advanced an initiative to implement real-time clinical trials. Elsewhere, UCB has made headlines for through an acquisition and its cancer research venture.  The top stories:    FDA moves… Read More

#News

#AI #Business #Genomics #Lab automation #SLAS2026

Lab automation strong despite global challenges

The world of drug discovery definitely kept us on our toes last year. Uncertainty in the market, not helped by the challenges created by changes in US drug pricing and tariffs, led to spending dips and nervousness throughout the sector.   SLAS2026 is a key point in the drug discovery calendar,… Read More

#Exclusive Content #Opinion